AUM Biosciences Ltd (CIK: 0001957252) EDGAR, Information, Filings... CompaniesBIO.Com

AUM Biosciences Ltd

Mailing address
10 ANSON ROAD, # 24-16 A/B INTERNATIONAL PLAZA, SINGAPORE, Cayman Islands, 079903
Phone
65 6808 6034
State location
Singapore
State of incorporation
Cayman Islands
Fiscal year end
March 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

AUM Biosciences Ltd (CIK: 0001957252) is an American company incorporated in the state of Singapore. Head office is located at 10 ANSON ROAD, # 24-16 A/B INTERNATIONAL PLAZA, SINGAPORE, Singapore, 079903. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. AUM Biosciences Ltd is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by AUM Biosciences Ltd

Filings	Format	Description	Filed/Effective	File/Film Number
425	Document	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001829126-23-004166 ( Act) Size: 0 KB	Jun-14-2023
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001829126-23-003740 (33 Act) Size: KB	May-24-2023	333-270483 23954256
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001829126-23-003635 (33 Act) Size: KB	May-22-2023	333-270483 23941709
EFFECT	Document	Acc-no: 9999999995-23-001407 (33 Act) Size: KB	May-12-2023	333-270483 23918027
425	Document	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001829126-23-003275 ( Act) Size: 0 KB	May-11-2023
425	Document	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001829126-23-003238 ( Act) Size: 0 KB	May-10-2023
F-4/A	Document	Amendment to Registration statement for securities issued by foreign private issuers in certain business combination transactions Acc-no: 0001829126-23-003059 (33 Act) Size: KB	May-02-2023	333-270483 23878911
F-4/A	Document	Amendment to Registration statement for securities issued by foreign private issuers in certain business combination transactions Acc-no: 0001829126-23-002703 (33 Act) Size: KB	Apr-13-2023	333-270483 23819219
F-4/A	Document	Amendment to Registration statement for securities issued by foreign private issuers in certain business combination transactions Acc-no: 0001829126-23-002400 (33 Act) Size: KB	Mar-30-2023	333-270483 23777409
F-4	Document	Registration statement for securities issued by foreign private issuers in certain business combination transactions Acc-no: 0001829126-23-001974 (33 Act) Size: KB	Mar-10-2023	333-270483 23725579
DRS/A	Document	Acc-no: 0001829126-23-001458 (33 Act) Size: KB	Feb-13-2023	377-06514 23618168
DRS	Document	Acc-no: 0001829126-22-020379 (33 Act) Size: KB	Dec-19-2022	377-06514 221472067

Recent 20 filings. View all AUM Biosciences Ltd filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

AUM Biosciences Ltd overview
AUM Biosciences Ltd job
AUM Biosciences Ltd stock
AUM Biosciences Ltd ownership
AUM Biosciences Ltd CEO
AUM Biosciences Ltd documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.